MaxCyte (LON:MXCT) Share Price Crosses Below 50-Day Moving Average – Time to Sell?

MaxCyte, Inc. (LON:MXCT)’s share price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 0.83 and traded as low as GBX 0.69. MaxCyte shares last traded at GBX 0.74, with a volume of 1,512,852 shares changing hands.

MaxCyte Stock Performance

The company has a quick ratio of 14.38, a current ratio of 12.39 and a debt-to-equity ratio of 9.70. The company has a 50 day moving average of GBX 0.82 and a 200 day moving average of GBX 1.30. The firm has a market cap of £796,967.22, a price-to-earnings ratio of -0.02 and a beta of 1.13.

About MaxCyte

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.